Sunday, August 23, 2015 10:02:55 PM
the latest DEF14-C https://www.sec.gov/Archives/edgar/data/814926/000093980215000038/schedule14c060415.htm state's they own 42.5%,but they were either too lazy,or chose not,to do the math.
Stewart Wallach,CEO. 147,618,822
Jeff Postal,Director .... 128,381,748
Jeff Guzy,Director ............. 832,000
Larry Sloven, Director ...... 792,000
Gerry McClinton, CFO, ..... 504,949
____________________________________________________________
TOTAL INSIDER SHARES: 278,129,519 or 38.523% of current 721,989,957 share's Outstanding as of June 30,2015
here are some link's for Going Private protocol's
http://www.sec.gov/answers/gopriv.htm
http://www.egsllp.com/GoingPrivatePresentation-FINAL.pdf
http://openscholarship.wustl.edu/cgi/viewcontent.cgi?article=2437&context=law_lawreview
Capstone Companie's,i believe,is incorporated in Florida,not Delaware,so there may be some difference's to some of the information in the above links.
during their latest proxy meeting they gathered 384,153,928 votes,or 53.2% of the outstanding.
That's 106,024,409 more then their own stock,so they must have gotten Involve's 67,979,425 and another 38,044,984 to vote with them (... the Fisher's might still own about 18,000,000 shares)
to go private it looks like they would have to make a satisfactory offer for the 443,860,438 share's the insider's don't own,an offer of 2 cent's a share would be a total of $8,877,208.76
Most shareholder's,imo,would reject a 2 cent's per share offer.
just my opinion,but I don't see where management would currently want to go private,Stewart Wallach has stated in the past that it is one of his goal's to get the stock uplisted to the NASDAQ..the companie's option's for raising capital are probably much better as a public company.
Recent CAPC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:55:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:14:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 06:12:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM